Wednesday, Apr 23, 2025 · SEC filings

What the smart money revealed on Apr 23

Real insider buys24insiders · $2.42M
Real insider sales21insiders · $35.3M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

297 insider filings came in. We hid 44 planned (10b5-1) sellers and 190 people whose filings were routine, like grants and tax withholding.

group

4 insiders at KeyCorp (KEY) bought $152K of stock

Roles: Chief Risk Officer, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Apr 21–22
$152K
group

3 insiders at Diameter Credit bought $1.07M of stock

Roles: CEO, CFO, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Apr 21
$1.07M
group

3 insiders at AIM ImmunoTech (AIM) bought $124K of stock

Roles: CEO, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Apr 11
$124K
trending_up

Texas Capital Bancshares (TCBI) Director Robert Stallings bought $471K

Open-market buys of more than one share class. Not a grant or an option exercise. Their past buys: 7 of 9 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 7 of 9 beat Traded Apr 21
$471K
trending_up

Ally Financial (ALLY) CFO Russell Hutchinson bought $253K

8,200 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 3 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 2 of 3 beat Traded Apr 22
$253K
trending_up

Cosmos Health (COSM) CEO Grigorios Siokas bought $63K

175,000 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 7 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 4 of 7 beat Traded Apr 22
$63K
trending_up

Neogen (NEOG) Chief Legal Officer Amy Rocklin bought $62.4K

12,500 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Apr 23
$62.4K
trending_down

AutoZone (AZO) Sr. Vice President Domingo Hurtado sold $17.6M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 159 shares directly.

Real sale Form 4 Traded Apr 22
$17.6M
trending_down

HEICO (HEI) Director Alan Schriesheim sold $12M

Not marked as a planned 10b5-1 sale. Sold 24% of the shares they held directly. Still holds 157,197 shares.

Real sale Form 4 Traded Apr 22
$12M
trending_down

Huntington Bancshares (HBAN) Chief Information Officer Kendall Kowalski sold $348K

Not marked as a planned 10b5-1 sale. Sold 27% of the shares they held directly. Still holds 70,281 shares.

Real sale Form 4 Sold 27% of stake Traded Apr 22
$348K
Show 10 more real buys
Show 18 more real sales
BLK BlackRock · Senior Managing Director J. Richard Kushel · Traded Apr 21
$1.7M
KR Kroger · Executive Vice President Timothy Massa · Traded Apr 22
$1.65M
HBAN Huntington Bancshares · Senior Exec. V.P. Brantley Standridge · Traded Apr 22
$964K
NIC Nicolet Bankshares · Director Susan Merkatoris · Traded Apr 21
$402K
NWN Northwest Natural Holding · Director David Anderson · Traded Apr 21
$322K
HEI HEICO · Director Frank Schwitter · Traded Apr 22
$143K
PTGX Protagonist Therapeutics · CFO Asif Ali · Traded Apr 22
$80.8K
HOMB Home Bancshares · Chief Accounting Officer Jennifer Floyd · Traded Apr 23
$68.6K
QMCO Quantum · President and CEO James Lerner · Traded Apr 21
$26.9K
ALLO Allogene Therapeutics · SVP Annie Yoshiyama · Traded Apr 21
$13.5K
QMCO Quantum · SVP Chief Admin Ofcr and Secy Brian Cabrera · Traded Apr 21
$10.4K
FNKO Funko · Chief Commercial Officer Andrew Oddie · Traded Apr 22
$10.2K
DNA Ginkgo Bioworks · Officer Mark Dmytruk · Traded Apr 21
$9.06K
DNA Ginkgo Bioworks · Officer Steven Coen · Traded Apr 21
$7.26K
PHR Phreesia · SVP David Linetsky · Traded Apr 21
$5.99K
WBHC Wilson Bank Holding · Director Lisa Pominski · Traded Apr 23
$4.5K
QMCO Quantum · Chief Accounting Officer Lewis Moorehead · Traded Apr 21
$1.73K
FNKO Funko · CFO Yves Le Pendeven · Traded Apr 22
$983

13F season

Holdings as of Mar 31, 2025 are due May 15

92 funds have filed so far. 80 filed for the quarter before.

Biggest real insider buys, Apr 17–23

Open-market buys by officers and directors, filed in the 7 days up to Apr 23.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist